SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike S1 (RBD) Recombinant Protein
SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike S1 (RBD) Recombinant Protein
Product Specifications
Product Name Alternative
2019-nCoV Spike Protein S1 (RBD) ; Spike Receptor Binding Domain Variant South Africa; 501Y.V2
UniProt
P0DTC2
Source
HEK293 cells
Field of Research
Infectious Disease & Virology
Concentration
1 mg/ml after reconstitution.
Purity
≥95% (SDS-PAGE)
Bioactivity
Binds to human ACE2.
Form
Lyophilized
Molecular Weight
~60kDa (SDS-PAGE)
Storage Conditions
Short Term StorageL: +4°C, Long Term Storage: -20°C, Handling Advice: After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. For maximum product recovery after thawing, centrifuge the vial before opening the cap. Use/Stability: Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.
Notes
For research use only.
NCBI Accession Number
QHD43416.1
Preservative
Lyophilized. Contains PBS.
AA Sequence
Receptor-binding domain (RBD) of SARS-CoV-2 Spike protein S1 (aa 319-541) containing the mutations K417N, E484K, N501Y is fused to the N-terminus of the Fc region of human IgG1.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog